{"schemaVersion":"peptidescanner-peptide-evidence-feed/v1","canonicalUrl":"https://peptidescanner.com/feeds/peptides/palopegteriparatide.json","peptide":{"slug":"palopegteriparatide","name":"Palopegteriparatide","url":"https://peptidescanner.com/peptides/palopegteriparatide/"},"release":{"label":"Beta · 17 Nov 2026","reviewedAt":"2026-11-17"},"entryCount":16,"entries":[{"objectId":"story:clinicaltrials-gov-nct07081997-palopegteriparatide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT07081997","domain":"Clinical trials","dateInSource":"2026-11-05","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07081997-palopegteriparatide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#clinicaltrials-gov-nct07081997-palopegteriparatide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.md#clinicaltrials-gov-nct07081997-palopegteriparatide-v1","contentSha256":"4732f1ee8ee067dd2f7f45fd22c873d64417cad1c0a1b93f4d5d880dc7ef7cd0"},{"objectId":"story:clinicaltrials-gov-nct07264634-palopegteriparatide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT07264634","domain":"Clinical trials","dateInSource":"2026-08-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07264634-palopegteriparatide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#clinicaltrials-gov-nct07264634-palopegteriparatide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.md#clinicaltrials-gov-nct07264634-palopegteriparatide-v1","contentSha256":"c0a7e64b22ea79cb4d16c76411886427619cad361a2394b05549ddaa9c1e0326"},{"objectId":"story:clinicaltrials-gov-nct07345494-palopegteriparatide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT07345494","domain":"Clinical trials","dateInSource":"2026-03-02","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07345494-palopegteriparatide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#clinicaltrials-gov-nct07345494-palopegteriparatide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.md#clinicaltrials-gov-nct07345494-palopegteriparatide-v1","contentSha256":"0f42abd6508a19dea870bb6c6af23611a1ab98e259b8268a419abdfe3c0e9ff4"},{"objectId":"story:clinicaltrials-gov-nct07706764-palopegteriparatide:v1","state":"current","stateChangedAt":"2026-11-15","title":"ClinicalTrials.gov record NCT07706764","domain":"Clinical trials","dateInSource":"2026-07-28","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07706764-palopegteriparatide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#clinicaltrials-gov-nct07706764-palopegteriparatide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.md#clinicaltrials-gov-nct07706764-palopegteriparatide-v1","contentSha256":"ba5bcab3eb0e8b06f9cf903c2f3cff24eaff95271bf65fbca9844fd73013a26b"},{"objectId":"story:fda-drugs-nda216490:v1","state":"current","stateChangedAt":"2026-11-15","title":"Drugs@FDA application NDA216490","domain":"Regulatory","dateInSource":"2024-08-09","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/fda-drugs-nda216490/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#fda-drugs-nda216490-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.md#fda-drugs-nda216490-v1","contentSha256":"a5926be8e401d5e2a0c877317faa71457fc7ba78f8d36f320dad34ff3cdfea14"},{"objectId":"story:federal-register-2025-16269:v1","state":"current","stateChangedAt":"2026-11-15","title":"Federal Register notice 2025-16269","domain":"Regulatory","dateInSource":"2025-08-26","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/federal-register-2025-16269/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#federal-register-2025-16269-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.md#federal-register-2025-16269-v1","contentSha256":"fa3b88fe22bb816841a935e8c80c5464338459ebd4f1be649ebdcc203a9911dd"},{"objectId":"story:federal-register-2026-10277:v1","state":"current","stateChangedAt":"2026-11-15","title":"Federal Register notice 2026-10277","domain":"Regulatory","dateInSource":"2026-05-22","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/federal-register-2026-10277/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#federal-register-2026-10277-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.md#federal-register-2026-10277-v1","contentSha256":"90028d6c73acec07c92ba1c33c520ce4846e40f5ab4a704f6c27e36fbd6b7ac1"},{"objectId":"story:pubmed-pmid-39437769-palopegteriparatide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Palopegteriparatide.","domain":"Literature metadata","dateInSource":"2025-01-06","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-39437769-palopegteriparatide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#pubmed-pmid-39437769-palopegteriparatide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.md#pubmed-pmid-39437769-palopegteriparatide-v1","contentSha256":"bbea7de7f4ebdb296913a9d4dce1ead9c897913c890b2645358da4933ef2b370"},{"objectId":"story:pubmed-pmid-41134515-palopegteriparatide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Value Contribution of Palopegteriparatide in Adult Patients with Chronic Hypoparathyroidism using Multicriteria Decision Analysis (MCDA).","domain":"Literature metadata","dateInSource":"2025-11-17","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-41134515-palopegteriparatide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#pubmed-pmid-41134515-palopegteriparatide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.md#pubmed-pmid-41134515-palopegteriparatide-v1","contentSha256":"86e19a0844999118a1b38441cdc279cea784bdeee5e6d57889149ab77a10757f"},{"objectId":"story:pubmed-pmid-41636590-palopegteriparatide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Palopegteriparatide for adults with chronic hypoparathyroidism: skeletal dynamics through 3 years of the phase 2 PaTH forward trial.","domain":"Literature metadata","dateInSource":"2026-10-01","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-41636590-palopegteriparatide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#pubmed-pmid-41636590-palopegteriparatide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.md#pubmed-pmid-41636590-palopegteriparatide-v1","contentSha256":"e6add9e18f483f79c504b96e86b1d233931eccf6685ca4d78f4363b255a2907b"},{"objectId":"story:pubmed-pmid-42139093-palopegteriparatide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Palopegteriparatide therapy for hypoparathyroidism: targeting the PTH receptor rouses the sleeping skeleton.","domain":"Literature metadata","dateInSource":"2026-09-27","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42139093-palopegteriparatide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#pubmed-pmid-42139093-palopegteriparatide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.md#pubmed-pmid-42139093-palopegteriparatide-v1","contentSha256":"52ba39380532b00bbeef636cb1356b76f2f12fe5f123058d0bbfbfc9e45b4d62"},{"objectId":"story:pubmed-pmid-42440695-palopegteriparatide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Pharmacodynamics of sustained levels of PTH following palopegteriparatide treatment in adults with hypoparathyroidism.","domain":"Literature metadata","dateInSource":"2026-08-13","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42440695-palopegteriparatide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#pubmed-pmid-42440695-palopegteriparatide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.md#pubmed-pmid-42440695-palopegteriparatide-v1","contentSha256":"e8ca92f24541447ded24ce9bcfc310f727483bf41011186e2d6d7b273db3821c"},{"objectId":"story:pubmed-pmid-42614145-palopegteriparatide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Palopegteriparatide treatment for hypoparathyroidism in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: a case series and literature update.","domain":"Literature metadata","dateInSource":"2026-08-20","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42614145-palopegteriparatide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#pubmed-pmid-42614145-palopegteriparatide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.md#pubmed-pmid-42614145-palopegteriparatide-v1","contentSha256":"f670493c0ee0a9aba176cd025d37f880fb3b0f71d33fa774cc355ac3a16df0cf"},{"objectId":"story:pubmed-pmid-42789535-palopegteriparatide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Off-label palopegteriparatide for severe pediatric postsurgical hypocalcemia.","domain":"Literature metadata","dateInSource":"2026-10-07","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42789535-palopegteriparatide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#pubmed-pmid-42789535-palopegteriparatide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.md#pubmed-pmid-42789535-palopegteriparatide-v1","contentSha256":"34c423343ea85275a5f95e7dbd4e3772c44ee1e1b59bae593bf310fc9a6524e3"},{"objectId":"story:pubmed-pmid-42871663-palopegteriparatide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Discontinuation of palopegteriparatide in chronic hypoparathyroidism without rebound hypocalcemia.","domain":"Literature metadata","dateInSource":"2026-10-15","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42871663-palopegteriparatide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#pubmed-pmid-42871663-palopegteriparatide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.md#pubmed-pmid-42871663-palopegteriparatide-v1","contentSha256":"669081e916a66e8c4aa5cece983ad88232aa9e9c2bb2eac82752ff96bda328ef"},{"objectId":"story:pubmed-pmid-42924498-palopegteriparatide:v1","state":"current","stateChangedAt":"2026-11-15","title":"Palopegteriparatide: Parathyroid Hormone Analog for the Treatment of Chronic Hypoparathyroidism in Adults.","domain":"Literature metadata","dateInSource":"2026-10-24","publishedAt":"2026-11-15","humanUrl":"https://peptidescanner.com/stories/pubmed-pmid-42924498-palopegteriparatide/","jsonUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.json#pubmed-pmid-42924498-palopegteriparatide-v1","markdownUrl":"https://peptidescanner.com/evidence/v1/peptides/palopegteriparatide.md#pubmed-pmid-42924498-palopegteriparatide-v1","contentSha256":"990d459ef7520632348f77f427c08da07197f17491cacc900dfde52d55f29da6"}]}
